John Rockwell

John Rockwell has extensive experience in the biotechnology sector, primarily focusing on method development, formulation development, and analytical support for biologics. John began a career as a Scientist at Oncobiologics Inc. from December 2011 to February 2013, where responsibilities included method development and instrument coordination. Following this, John worked at Merck from February 2013 to October 2014, transitioning from Scientist to Associate Scientist roles, involved in drug product manufacturing and analytical method development for biologics. Subsequently, John served as a Senior Scientist and Group Leader at Bristol-Myers Squibb from October 2014 to September 2016, managing projects in a GMP environment. Most recently, John held a managerial position at Catalent Pharma Solutions, leading a team on method validation and pre-formulation studies. John earned a Bachelor of Science degree in Biochemistry from Rutgers University in 2006.